CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2025 financial results after the market close on Monday, July 21, ...
Medpace has had an excellent financial performance. Its revenues increased by 495.26% between 2016Q2 and 2024Q3. Meanwhile, its current ROE is 54.08%. The company focused on small and mid-size ...
Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its fourth quarter and fiscal year 2025 financial results after the market close on Monday, February 9, 2026. The ...
Investment management company Vulcan Value Partners recently released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The third quarter was a good one for the ...
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2025 financial results after the market close on Wednesday, October ...
Revenue of $558.6 million in the first quarter of 2025 increased 9.3% from revenue of $511.0 million for the comparable prior-year period, representing a backlog conversion rate of 19.2%. Net new ...
August J Troendle, CEO at Medpace Hldgs MEDP, reported an insider sell on July 29, according to a new SEC filing. Medpace is a late-stage contract research organization that provides full-service drug ...
Investor's Business Daily on MSN
S&P 500 financial titan BlackRock leads five stocks to watch
S&P 500 components BlackRock and GE Aerospace are among the five stocks to watch in next week's shortened stock market action ...
During the last three months, 8 analysts shared their evaluations of Medpace Hldgs (NASDAQ:MEDP), revealing diverse outlooks from bullish to bearish. Summarizing their recent assessments, the table ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback